In the current study, there was evidence for heterogeneity in the passive immunotherapy effect by baseline antibody status on sustained recovery and a marginally significant trend towards a difference for the composite safety endpoint.
← all excerpts
Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials.
1
—
—